ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 171 filers reported holding ANI PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,402 | +0.6% | 1,471 | -6.8% | 0.00% | – |
| Q2 2023 | $84,868 | +334.3% | 1,579 | +220.9% | 0.00% | – |
| Q1 2023 | $19,540 | -18.7% | 492 | -18.0% | 0.00% | – |
| Q4 2022 | $24,023 | +71.6% | 600 | +37.0% | 0.00% | – |
| Q3 2022 | $14,000 | -17.6% | 438 | -24.1% | 0.00% | – |
| Q2 2022 | $17,000 | – | 577 | +4338.5% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 13 | -35.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -83.3% | 20 | -90.9% | 0.00% | – |
| Q4 2020 | $6,000 | -33.3% | 220 | -33.9% | 0.00% | – |
| Q3 2020 | $9,000 | -18.2% | 333 | +1.8% | 0.00% | – |
| Q2 2020 | $11,000 | -73.8% | 327 | -68.3% | 0.00% | – |
| Q1 2020 | $42,000 | – | 1,031 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |